Kymera Therapeutics Inc. (KYMR)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary 
XKLS $
104. 78
-3.36
-3.1071%
$
9.25B Market Cap
- P/E Ratio
- Div Yield
488,723 Volume
-2.54 Eps
$ 108.14
Previous Close 
Want to track KYMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kymera Therapeutics Inc. (KYMR) Statistics
Valuation metrics
Market Cap 9.25B
Enterprise value 9.2B
Trailing P/E (ttm) -34.58
Forward P/E -
PEG ratio -6.22
Price/Sales (ttm) 88.06
Price/Book (mrq) 7.31
Enterprise Value/Revenue 87.66
Enterprise Value/EBITDA -31.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.18M
Average volume (90 days) 745.37K
Price summary
52-Week low 55.26
52-Week high 130.05
Beta -
50-Day moving average 118.2
200-Day moving average 91.08
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.85%
Operating margin -3.34%
Operational effectiveness
Return on assets -0.18%
Return on equity -0.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 9.83%
Book value per share (mrq) 15.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
